华领医药真比拜耳更会卖降糖药

界面
28 Mar

界面新闻记者 |黄华界面新闻编辑 |谢欣3月27日,华领医药发布2024年度业绩数据称,公司于期内实现销售收入2.56亿元,同比增加234%。该公司的降糖药多格列艾汀片(商品名:华堂宁)销售表现良好,帮助企业的年收入首度破亿。这也是华堂宁被纳入国家医保药品目录后的首个完整年。自今年1月起,华领医药已从合作伙伴拜耳手中全面接管华堂宁在国内的商业化工作。在截至2月末的两个月内,华堂宁的销售数量达到...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10